KTX-207

N/A

Report date: 2025/09/09 17:51:05
NME

Base Information

Drug NameKTX-207
Drug Alias NameKTX207KTX-207
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKatalytic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKatalytic Therapeutics IncUniversity Of Glasgow
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A